For the sake of the perfect appearance of the women had a variety of ways to support the appearance and beauty themselves. But, now they must be very careful, especially for those who put breast implants.
Around 250 women in her breast silicone implants installer made by Poly Implant Prothese (PIP) sued six clinics in the UK. Allegedly this industry made silicone implants contain toxins that harm and damage their bodies. Not only the PIP of the complaint, even about 40 thousand women in England who undergo silicone implant surgery and breast reconstruction surgery at a clinic complain of similar things.
The women who complain of having disabilities demanded that the company's pharmaceutical industry and several clinics in the UK examined or through legal channels. PIP, the pharmaceutical industry company that manufactures silicone implants in France, began to receive sanctions from the local government because it has a product that is not worth testing. Silicon-made pharmaceutical industry uses raw materials are cheap and potentially explosive.
This accusation of crime scandal in France this weekend more exciting when the health officials at local government moved swiftly after receiving reports of eight cases of cancer in women who had received implants of the company's PIP. Health departments in France through the Head of Medicines and Healthcare Products Regulatory Agency (MHRA) is directly discuss with health experts from the Netherlands, Portugal, Italy, Ireland, Hungary, Austria, Denmark, and Malta.
"They all agreed that there was no evidence of any increased incidence of cancer related with breast implants PIP. Also, there is no evidence of any rupture rate and the assumption of proportion. We tried to discuss this matter in line with findings from the UK," said Doch Mayer, one drug and food research analyst in France.
Doch even support the routine extraction of the implant. "We would urge any patient with any concerns about their breast implants to seek advice from their surgeon," he said. "Any decision about funding the removal of these implants will be determined on a case by case basis according to clinical needs."
Based on reports to the MHRA believed to be about one percent of women in the UK with PIP implants had failed implants, including rupture, the figure is lower than the data from the French medical device regulatory authorities and who have demonstrated a failure rate of about 5% in France. "Many women with implants PIP is said by lawyers in court cases have been experiencing the problem of suffering, including rupture and leak, when in fact not the case," said the official.
Mark Harvey, a lawyer in France said it was taking legal action who want to pursue claims against insurance companies PIP. According to Mark, this issue should not be sharpened that it will adversely affect the relationship among countries
